Editorial - Journal of Aging and Geriatric Psychiatry (2025) Volume 9, Issue 2

Geriatric anxiety: Assessment, treatment, future direction.

Dr. Ana Martins^*

Department of Medicine, University of Lisbon

*Corresponding Author:

Dr. Ana Martins
Department of Medicine
University of Lisbon.
E-mail: ana.martns@unlisboa.pt

Received : 05-Aug-2025, Manuscript No. AAAGP-25-197; Editor assigned : 07-Aug-2025, PreQC No. AAAGP-25-197(PQ); Reviewed : 27-Aug-2025, QC No AAAGP-25-197; Revised : 05-Sep-2025, Manuscript No. AAAGP-25-197(R); Published : 16-Sep-2025 , DOI : 10.35841/aaagp-9.2.197

Citation: Martins DA. Geriatric anxiety: Assessment, treatment, future direction. J Age Geriat Psych. 2025;09(02):197.

Introduction

Current research synthesizes the understanding of geriatric anxiety, pinpointing significant gaps and challenges in its assessment and treatment. It highlights the high prevalence and diverse clinical presentations of anxiety disorders among older adults, emphasizing the critical need for more tailored interventions and diagnostic tools specific to this demographic[1].

The landscape of digital mental health interventions tailored for anxiety in older adults is actively being explored. This includes an assessment of their effectiveness, usability, and potential barriers to implementation. While promising, further research is crucial to optimize their design and ensure equitable access and engagement for the geriatric population, ensuring technology serves this vital need[2].

Prevalence and key risk factors associated with anxiety symptoms among community-dwelling older adults are critical areas of study. Findings consistently highlight crucial demographic and health-related factors that predispose older individuals to anxiety. These insights are incredibly valuable for developing targeted prevention programs and early intervention strategies that can make a real difference[3].

A comprehensive assessment of the efficacy and safety of various pharmacological interventions for anxiety disorders in older adults is essential. This work addresses the complexities inherent in prescribing medications for this population, considering potential drug interactions and age-related physiological changes. It recommends evidence-based approaches for effective symptom management, focusing on patient safety[4].

Non-pharmacological interventions for reducing anxiety in older adults have been thoroughly evaluated through systematic reviews and meta-analyses. Compelling insights are offered into beneficial therapies, such as Cognitive Behavioral Therapy (CBT), mindfulness-based practices, and physical exercise. This research provides a strong evidence base for successfully integrating these diverse approaches into comprehensive care plans[5].

The complex co-occurrence of anxiety and depressive symptoms in older adults with mild cognitive impairment is a significant area of focus. This research highlights how these affective symptoms significantly impact cognitive decline, functional independence, and overall quality of life. It strongly underscores the necessity for integrated assessment and management approaches within this particularly vulnerable population[6].

The COVID-19 pandemic profoundly impacted anxiety and depressive symptoms in older adults, as revealed by a comprehensive meta-analysis. It quantifies significant increases in psychological distress, primarily driven by factors like isolation, health concerns, and broad societal changes. This work highlights the urgent need for tailored mental health support and public health interventions for this demographic during ongoing crises[7].

Best practices for assessing and treating anxiety in older adults are crucial, considering their unique age-related presentations and frequent comorbidities. This offers practical guidance for clinicians, aiming to improve diagnostic accuracy and facilitate the implementation of effective, individualized treatment plans. These plans must account for the specific complexities of geriatric care, ensuring optimal patient outcomes[8].

Cognitive Behavioral Therapy (CBT) stands out as a potent intervention for late-life anxiety, with strong evidence from meta-analyses. It consistently demonstrates a significant impact on reducing anxiety symptoms across various settings and formats. This robust finding solidifies CBT's role as a first-line psychological treatment option for older adults facing a range of anxiety disorders[9].

A narrative review delves into the intricate neurobiological mechanisms underlying anxiety in the context of aging. It discusses how age-related brain changes, alterations in neurotransmitter systems, and specific biomarkers contribute to both the vulnerability and distinct symptom presentation of anxiety in older adults. This forms a crucial foundation for future research into targeted biological interventions[10].

Conclusion

Geriatric anxiety is a significant concern, marked by its high prevalence and varied clinical presentations, underscoring a critical need for more tailored interventions and diagnostic tools specific to older adults. Research highlights the importance of synthesizing the current understanding of geriatric anxiety, identifying key research gaps, and addressing challenges in its assessment and treatment. Identifying the prevalence and specific risk factors for anxiety symptoms among community-dwelling older adults is crucial for developing effective prevention programs and early intervention strategies. These risk factors often include demographic and health-related elements that predispose older individuals to anxiety. Effective assessment and treatment of anxiety in older adults demand consideration of their unique age-related presentations and frequent comorbidities. This involves practical guidance for clinicians to enhance diagnostic accuracy and implement individualized treatment plans that account for the complexities of geriatric care. Pharmacological interventions for anxiety disorders in this demographic require a comprehensive assessment of efficacy and safety, paying close attention to potential drug interactions and age-related physiological changes to recommend evidence-based approaches. Concurrently, non-pharmacological interventions, such as Cognitive Behavioral Therapy (CBT), mindfulness-based practices, and exercise, have demonstrated substantial effectiveness in reducing anxiety. CBT, in particular, is noted as a potent first-line psychological treatment. The landscape of digital mental health interventions for anxiety in older adults is evolving, showing promise, but optimization is still needed to address usability and access barriers. The co-occurrence of anxiety and depressive symptoms is particularly relevant in older adults with mild cognitive impairment, where these affective symptoms can profoundly impact cognitive decline, functional independence, and overall quality of life, necessitating integrated management. Furthermore, the neurobiological mechanisms underpinning anxiety in aging, including age-related brain changes and neurotransmitter alterations, provide a foundation for future biological interventions. Global events, like the COVID-19 pandemic, have also been shown to significantly exacerbate anxiety and depressive symptoms in older adults due to increased isolation and health concerns, reinforcing the need for targeted mental health support during crises.

References

1. Ana IFRP, Cláudia S, Lúcia SFC. Geriatric Anxiety: A Scoping Review. Psychogeriatr. 2022;22(5):697-709.

Indexed at, Google Scholar, Crossref

1. Cécile K, Annegret MN, Jan S. Digital mental health interventions for anxiety in older adults: A scoping review. Clin Psychol Psychother. 2023;30(2):226-248.

Indexed at, Google Scholar, Crossref

1. Zhaoli W, Xiaoyun L, Meili X. Prevalence and risk factors of anxiety symptoms among community-dwelling older adults: A cross-sectional study. BMC Geriatr. 2022;22(1):363.

Indexed at, Google Scholar, Crossref

1. Marina LST, Luiza BMR, Jennifer SHS. Pharmacological treatment of anxiety disorders in older adults: a systematic review of the literature. Arch Gerontol Geriatr. 2021;94:104374.

Indexed at, Google Scholar, Crossref

1. Yu H, Bin H, Yu Z. Non-pharmacological interventions for anxiety in older adults: A systematic review and meta-analysis. J Psychiatr Res. 2021;137:233-247.

Indexed at, Google Scholar, Crossref

1. Candelaria R, Julia CP, María CAL. Anxiety and depressive symptoms in older adults with mild cognitive impairment: A systematic review. J Affect Disord. 2021;295:1083-1094.

Indexed at, Google Scholar, Crossref

1. Sara R, Laura GG, Elisa L. Impact of the COVID-19 pandemic on anxiety and depressive symptoms in older adults: a systematic review and meta-analysis. Aging Ment Health. 2023;27(11):2153-2166.

Indexed at, Google Scholar, Crossref

1. Brent PF, Barry AE, Kathleen RH. Assessment and Treatment of Anxiety in Older Adults. Curr Psychiatr Rep. 2020;22(7):35.

Indexed at, Google Scholar, Crossref

1. Yael H, Dana M, Daphna B. Cognitive Behavioral Therapy for Late-Life Anxiety: A Meta-Analysis. J Consult Clin Psychol. 2023;91(7):437-450.

Indexed at, Google Scholar, Crossref

1. Ana CCP, Cláudia P, Paula C. Anxiety, aging, and the brain: A narrative review of neurobiological correlates. Curr Opin Psychiatry. 2020;33(6):524-531.

Indexed at, Google Scholar, Crossref